202
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study

, , , , , & show all
Pages 1123-1139 | Published online: 15 Jul 2019

References

  • Collaboration NRF. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet . 2016;387(10027):1513–1530. doi:10.1016/S0140-6736(16)00618-8 27061677
  • Rowley WR , Bezold C , Arikan Y , Byrne E , Krohe S . Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag . 2017;20(1):6–12. doi:10.1089/pop.2015.0181 27124621
  • Lastra G , Syed S , Kurukulasuriya LR , Manrique C , Sowers JR . Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin . 2014;43(1):103–122. doi:10.1016/j.ecl.2013.09.005
  • Ko S-H , Kwon H-S , Kim DJ , et al. Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth korean national health and nutrition examination survey in 2011. Diabetes Metab J . 2014;38(1):51–57. doi:10.4093/dmj.2014.38.1.51 24627828
  • Hu G , Jousilahti P , Tuomilehto J . Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. Eur Heart J . 2007;28(24):3059–3066. doi:10.1093/eurheartj/ehm501 17981826
  • Mohan MM . Prevalence and risk factors of microalbuminuria in type 2 diabetes mellitus. Ijam . 2017;2(4):283–386.
  • Currie G , Delles C . Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis . 2014;7:13.
  • Alharf A , Cleland S , Webster J , McInnes G , Padmanabhan S . Microalbuminuria in subjects with hypertension attending specialist blood pressure clinics. J Hum Hypertens . 2016;30(9):527–533. doi:10.1038/jhh.2015.116 26674756
  • Pascual JM , Rodilla E , Costa JA , Garcia-Escrich M , Gonzalez C , Redon J . Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertensionnovelty and significance. Hypertension . 2014;64(6):1228–1234. doi:10.1161/HYPERTENSIONAHA.114.04273 25245391
  • Ali A , Taj A , Amin MJ , Iqbal F , Iqbal Z . Correlation between microalbuminuria and hypertension in type 2 diabetic patients. Pak J Med Sci . 2014;30(3):511. doi:10.12669/pjms.306.5684 24948969
  • Janghorbani M , Amini M . Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. Diabetes Res Clin Pract . 2005;70(1):71–80. doi:10.1016/j.diabres.2005.02.017 16126125
  • Amini M , Safaei H , Aminorroaya A . The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in Isfahan, Iran. Rev Diabet Stud . 2007;4(4):242. doi:10.1900/RDS.2007.4.242 18338078
  • Association AD. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabet . 2015;33(2):97. doi:10.2337/diaclin.33.2.97
  • Amer H , Fidler M , Myslak M , et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant . 2007;7(12):2748–2756. doi:10.1111/j.1600-6143.2007.02006.x 17941956
  • Perk J , De Backer G , Gohlke H , et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis . 2012;223(1):1–68. doi:10.1016/j.atherosclerosis.2012.05.007 22698795
  • Mancia G , De Backer G , Dominiczak A , et al. ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens . 2007;25(9):1751. doi:10.1097/HJH.0b013e3282f0580f 17762635
  • Friedewald WT , Levy RI , Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem . 1972;18(6):499–502.4337382
  • Gibbons RD , Hedeker D , DuToit S . Advances in analysis of longitudinal data. Annu Rev Clin Psychol . 2010;6:79–107. doi:10.1146/annurev.clinpsy.032408.153550 20192796
  • Spiegelhalter D , Thomas A , Best N , Lunn D . OpenBUGS User Manual, Version 3.0. 2 . Cambridge: MRC Biostatistics Unit; 2007.
  • Fonseca V . Diabetes: Improving Patient Care . New York: Oxford University Press; 2009.
  • Jahangiri-Noudeh Y , Akbarpour S , Lotfaliany M , et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study. PLoS One . 2014;9(12):e112639. doi:10.1371/journal.pone.0112639 25461381
  • Mattix HJ , Hsu C-Y , Shaykevich S , Curhan G . Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol . 2002;13(4):1034–1039.11912263
  • Monster TB , Janssen WM , de Jong PE . Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med . 2001;161(16):2000–2005.11525702
  • Zoungas S , Woodward M , Li Q , et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia . 2014;57(12):2465–2474. doi:10.1007/s00125-014-3369-7 25226881
  • Bała MM , Płaczkiewicz-Jankowska E , Topór-Mądry R , et al. Characteristics of patients with type 2 diabetes of short duration in Poland. Pol Arch Med Wewn . 2009;119:533–540.19776697
  • Harris MI , Klein R , Welborn TA , Knuiman MW . Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care . 1992;15(7):815–819. doi:10.2337/diacare.15.7.815 1516497
  • Ketema EB , Kibret KT . Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health . 2015;73(1):43. doi:10.1186/s13690-015-0088-6 26413295
  • Kohnert K-D , Heinke P , Vogt L , Salzsieder E . Utility of different glycemic control metrics for optimizing management of diabetes. World J Diabetes . 2015;6(1):17. doi:10.4239/wjd.v6.i1.17 25685275
  • Fa’iza Abdullaha TMH , Norc MBM , MAa MA , Ismaild IZ . Prevalence of hypertension and glycaemic control in adult type-2 diabetes patients: a preliminary retrospective cohort study in Kuantan, Pahang, Malaysia. Int Med J Malaysia . 2017;16:1.
  • Skyler JS , Bergenstal R , Bonow RO , et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. Circulation . 2009;119(2):351–357. doi:10.1161/CIRCULATIONAHA.108.191305 19095622
  • Rodríguez-Gutiérrez R , Montori VM . Glycemic control for patients with type 2 diabetes mellitus. Circ Cardiovasc Qual Outcomes . 2016 CIRCOUTCOMES. 116.002901. doi:10.1161/CIRCOUTCOMES.116.002901
  • Zoungas S , Chalmers J , Ninomiya T , et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia . 2012;55(3):636–643. doi:10.1007/s00125-011-2404-1 22186981
  • Russo GT , Giorda CB , Cercone S , Nicolucci A , Cucinotta D , Group BS . Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study. PLoS One . 2014;9(10):e109702. doi:10.1371/journal.pone.0109702 25347846
  • McVeigh GE , Bratteli CW , Morgan DJ , et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension . 1999;33(6):1392–1398.10373222
  • Aziz KM , Al-Qahtani M . Association between non-HDL and HDL cholesterol with microalbuminuria in patients with diabetes. J Diabetol . 2013;1:4.
  • Contreras F , Lares M , Castro J , et al. Determination of non-HDL cholesterol in diabetic and hypertensive patients. Am J Ther . 2010;17(3):337–340. doi:10.1097/MJT.0b013e3181c1233c 20479581
  • Popoola OA , Folaranmi OM . Hypertriglyceridemia and non-HDL cholesterol in the development of diabetic nephropathy. Eur J Pharm Med Res . 2015;2:2.
  • Kim S , Sugar CA , Belin TR . Evaluating model‐based imputation methods for missing covariates in regression models with interactions. Stat Med . 2015;34(11):1876–1888. doi:10.1002/sim.6435 25630757
  • Kahlert J , Gribsholt SB , Gammelager H , Dekkers OM , Luta G . Control of confounding in the analysis phase–an overview for clinicians. Clin Epidemiol . 2017;9:195. doi:10.2147/CLEP.S129886 28408854